Susanne M. Arnold, MD

Susanne Arnold, MD has over twenty years of experience in clinical and translational research in cancer therapeutics. In 2003, Dr. Arnold received the SWOG Young Investigator Award and was awarded the Shumate Professorship in Cancer Research in 2007, and the Buck Lung Chair in Lung Cancer Research in 2012. She has numerous research interests including the development of novel anti-cancer agents, such as AR-67, among others. In addition, she is the principal investigator of over 14 investigator-initiated clinical trials in lung and head and neck cancer, has authored 44 original manuscripts, trained over 20 fellows and countless residents in lung and head and neck cancer oncology. She serves as a clinical mentor for several post-doctoral students in pharmaceutical sciences and the medical oncology fellowship program. As the principal investigator of the Lung Cancer Research Initiative, funded by the Department of Defense, and the Marty Driesler Lung Cancer Project, funded by the HRSA and CDC, she has collaborated extensively with other clinicians, epidemiologists, behavioral and basic scientists, utilizing cancer registry data and accumulated field research in rural Appalachia to study populations at high risk of developing lung cancer. Her current research interests include development of novel therapeutics in solid tumors, drug development of nanotechnology-designed compounds and delivery formulations, the utilization of new drug combinations in lung and head and neck cancer, and the use of low-dose radiation as sensitizer of chemotherapy, in addition to the investigation of disparities in lung cancer incidence in Appalachian Kentucky and mechanism of development of lung cancer in this region.